Antithrombotic drugs: Mechanisms of actionMechanism of action of dipyridamole
References (37)
- et al.
Mode of action of dipyridamole on human platelets
Thromb. Res.
(1979) - et al.
Activation and inhibition of blood platelet adenylate cyclase by adenosine or by 2-chloroadenosine
Life Sci.
(1972) - et al.
Effects of prostacyclin (PGX) on cyclic AMP concentrations in human platelets
Prostaglandins
(1977) - et al.
Platelet function studies in coronary artery disease. X. Effects of dipyridamole
Am. J. Cardiol.
(1981) - et al.
Stimulation of prostacyclin by dipyridamole
Lancet
(1979) - et al.
Dipyridamole and platelet aggregation
Lancet
(1978) - et al.
Dipyridamole and platelet function
Lancet
(1978) - et al.
Panganamala: A study of three vasodilating agents as selective inhibitors of thromboxane A2 biosynthesis
Biochem. Biophys. Res. Commun.
(1978) Die pharmakologischen Eigenschaften der neuen coronareweiternden Substanz 2,6-Bis (diaethanolamino)-4,8 dipiperidino-pyrimido (5,4-d) pyrimidin
Arzneim. Forsch./Drug Res.
(1959)- et al.
Influence of a pyrimidopyrimidine derivative on deamination of adenosine by blood
Berne: Circulat. Res.
(1964)
Inhibition by adenosine and by 2-chloroadenosine of the formation and embolizaton of platelet thrombi
Nature (Paris)
(1964)
Effect of a pyrimidopyrimidine derivative on thrombus formation in the rabbit
Nature (Paris)
(1965)
Pharmacology of dipyridamole and its derivatives
Thrombos. Diathes. Haemorrh. (Stuttg.) (Suppl.)
(1970)
Effect of dipyridamole and prostacyclin on rabbit platelet adherence in vitro and in vivo
J. Lab. Clin. Med.
(1982)
Dipyridamole as an antithrombotic agent: an intricate mechanism of action
Studies of platelet and fibrinogen kinetics in patients with prosthetic heart valves
N. Engl. J. Med.
(1970)
Platelet and fibrinogen consumption in man
N. Engl. J. Med.
(1972)
Cited by (0)
Copyright © 1983 Published by Elsevier Ireland Ltd.